National COVID Cohort Collaborative Funding

Open Funding Opportunities

The Clinical and Translational Science Awards (CTSA) Program hubs and other entities can contribute data to the N3C as soon as the NCATS Data Transfer Agreement (DTA) has been executed.

Because of the national urgency and the need to make this resource available, NCATS encourages interested parties to contact its Office of Strategic Alliances at for instructions on executing the DTA. The goal is to start acquiring clinical data immediately and show proof of principle for answering important COVID-19 research and health care questions as soon as possible.

If needed, limited funds are available to current CTSA UL1s under NOT-TR-20-028 Emergency NOSI to support personnel and resources for data transfer (awards anticipated to be $50,000 to $100,000 Total Costs).

NOT-TR-20-028 includes rolling submission of applications; however, as the end of the fiscal year approaches, NCATS must defer some applications for FY21 funding considerations.

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Neither a DTA nor a data use agreement (DUA) need to be in place before submission of an application in response to NOT-TR-20-028; awards will be issued with restrictive terms and conditions that prohibit use of funds for these activities until the DTA and/or DUA is executed.


For questions about executing the DTA, contact

For other questions about the N3C, contact